The most recent data, relating to a period between 105 and 112 days from the first dose of the Covid-19 vaccine, suggest "protracted protection". This is indicated by the second report drawn up by the 'Covid-19 vaccine surveillance' working group of the Istituto Superiore di Sanità (Iss) and the Ministry of Health, which updates that of last May 15 and also this result of the joint analysis of the registry data national vaccines and integrated surveillance Covid-19 "Starting from 105-112 days after vaccination - the report reads - there is a further reduction in the risk of diagnosis, with a similar effect in men, women and people in different groups of age ". The data confirm those found in the first report, relating to 13.7 million people vaccinated,with the risk of death dropping by 95% and the reduction in the risk of receiving a diagnosis and being admitted to intensive care by 80% and 90% respectively.
The new report, referring to about 14 million people vaccinated with at least one dose, comes to an assessment over 130 days after the first dose was administered. Compared to the previous report, in the population studied there was an increase in vaccinated subjects in the age group 40 years and over and there was an increase in vaccinations with Comirnaty (Pfizer / BioNTech) and Vaxzevria (AstraZeneca) and the start of administration of the Janssen vaccine (Johnson & Johnson).
